EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta's Rhenium-SCT

/PRNewswire/ -- OncoBeta® GmbH has today announced a world-first from Australia, with the first patients treated with Rhenium-SCT® as part of the global phase...

Related Keywords

Germany ,New York ,United States ,Australia ,Austria ,Garching ,Bayern ,Munich ,United Kingdom ,Australian ,Ken Rikard Bell ,Gerhard Dahlhoff ,Oncobeta Gmb ,Therapeutic Nuclear Medicine ,Instagram ,Australian Nuclear Science ,Linkedin ,Facebook ,Technology Organisation ,Skin Study ,Personalised Irradiation ,South Coast Radiology ,Gold Coast ,John Flynn Private ,Radiation Oncologist ,Associate Professor Siddhartha Baxi ,Patient Reported Outcome Measures ,Clinical Study ,Medical Director ,Oncobeta Gmbh ,Beta Australia Country Manager ,Skin Cancer Therapy ,Basal Cell Carcinomas ,Squamous Cell Carcinomas ,Disease Cancer Collaboration ,Radionuclide Therapy ,Squamous Cell ,Risk Factors ,